Add to ORKGCopyright © 2015 Afshin A. Divani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The use of combined hormonal contraceptives has been reported to increase the level of C-reactive protein (CRP). We assessed the effect of hormonal contraceptive use on inflammatory cytokines including CRP, monocyte chemotactic protein-1, soluble tumor necrosis factor (sTNF), interleukin-6 (IL-6), and soluble CD40 ligand. We used 79 female subjects (19 to 30 years old) who were combined oral contraceptives users
Background: C-reactive protein (CRP) represents an independent risk factor for coronary disease and ...
BACKGROUND: Hormonal contraception is commonly used worldwide, but its systemic effects across lipop...
OBJECTIVE: Women's cardiovascular risk factors, including inflammatory markers such as C-reactive pr...
The use of combined hormonal contraceptives has been reported to increase the level of C-reactive pr...
WOS: 000480626400035Purpose: The aim of the study is examine the effect of oral contraceptives on th...
OBJECTIVE: To evaluate the effect of third-generation oral contraceptives on high-sensitivity C-reac...
Objective & study design: In a parallel design, 23 and 22 healthy pre-menopausal women were randomly...
Polycystic ovary syndrome is associated with dyslipidemia, dysglycemia, metabolic syndrome, and low-...
<p>Estrogens and progestins are known to have profound effects on the immune system and may modulate...
BACKGROUND: No studies have examined the effects of oral hormonal contraception on chronic low-grad...
C-reactive protein (CRP) is a well-established marker of inflammation. The level of CRP is affected ...
This study investigated the association between synthetic ovarian hormone use [i.e., the oral contra...
BACKGROUND: Young to middle-aged women are more likely than men to be diagnosed with irritable bowel...
BACKGROUND: C-reactive protein (CRP) is a well-established marker of inflammation. The level of CRP ...
C-reactive protein (CRP) is one of the most commonly used markers of acute phase reaction in clinica...
Background: C-reactive protein (CRP) represents an independent risk factor for coronary disease and ...
BACKGROUND: Hormonal contraception is commonly used worldwide, but its systemic effects across lipop...
OBJECTIVE: Women's cardiovascular risk factors, including inflammatory markers such as C-reactive pr...
The use of combined hormonal contraceptives has been reported to increase the level of C-reactive pr...
WOS: 000480626400035Purpose: The aim of the study is examine the effect of oral contraceptives on th...
OBJECTIVE: To evaluate the effect of third-generation oral contraceptives on high-sensitivity C-reac...
Objective & study design: In a parallel design, 23 and 22 healthy pre-menopausal women were randomly...
Polycystic ovary syndrome is associated with dyslipidemia, dysglycemia, metabolic syndrome, and low-...
<p>Estrogens and progestins are known to have profound effects on the immune system and may modulate...
BACKGROUND: No studies have examined the effects of oral hormonal contraception on chronic low-grad...
C-reactive protein (CRP) is a well-established marker of inflammation. The level of CRP is affected ...
This study investigated the association between synthetic ovarian hormone use [i.e., the oral contra...
BACKGROUND: Young to middle-aged women are more likely than men to be diagnosed with irritable bowel...
BACKGROUND: C-reactive protein (CRP) is a well-established marker of inflammation. The level of CRP ...
C-reactive protein (CRP) is one of the most commonly used markers of acute phase reaction in clinica...
Background: C-reactive protein (CRP) represents an independent risk factor for coronary disease and ...
BACKGROUND: Hormonal contraception is commonly used worldwide, but its systemic effects across lipop...
OBJECTIVE: Women's cardiovascular risk factors, including inflammatory markers such as C-reactive pr...